Insider Transactions in Q2 2023 at Avantor, Inc. (AVTR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2023
|
Michael Stubblefield President & CEO |
BUY
Bona fide gift
|
Indirect |
40,000
+7.85%
|
-
|
|
May 26
2023
|
Michael Stubblefield President & CEO |
SELL
Bona fide gift
|
Direct |
40,000
-3.73%
|
-
|
|
May 17
2023
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
106,200
-8.3%
|
$2,124,000
$20.28 P/Share
|
|
May 17
2023
|
Justin Miller EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
12,449
-11.77%
|
$248,980
$20.28 P/Share
|
|
May 17
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
15,706
-15.92%
|
$314,120
$20.28 P/Share
|
|
May 17
2023
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
18,917
-18.14%
|
$378,340
$20.28 P/Share
|
|
May 17
2023
|
Thomas A Szlosek EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,261
-23.09%
|
$465,220
$20.28 P/Share
|
|
May 17
2023
|
Frederic Vanderhaegen EVP, Americas and Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
2,210
-1.18%
|
$44,200
$20.28 P/Share
|
|
May 17
2023
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-2.54%
|
$11,060
$20.28 P/Share
|
|
May 17
2023
|
Gerard Brophy EVP, Biopharma Production |
SELL
Payment of exercise price or tax liability
|
Direct |
19,683
-18.11%
|
$393,660
$20.28 P/Share
|
|
May 11
2023
|
Juan Andres Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+19.73%
|
-
|
|
May 11
2023
|
Joseph R Massaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+34.7%
|
-
|
|
May 11
2023
|
Lan Kang Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+31.09%
|
-
|
|
May 11
2023
|
Jonathan M Peacock Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+5.01%
|
-
|
|
May 11
2023
|
John Carethers Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+32.6%
|
-
|
|
May 11
2023
|
Mala Murthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+34.49%
|
-
|
|
May 11
2023
|
Gregory L Summe Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+23.16%
|
-
|
|
May 11
2023
|
Michael Severino Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+21.9%
|
-
|
|
May 11
2023
|
Christi Shaw Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,808
+21.29%
|
-
|
|
Apr 16
2023
|
Randy Lee Stone EVP, Laboratory Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
48,332
+50.0%
|
-
|
|
Apr 11
2023
|
Christophe Couturier EVP, AMEA |
SELL
Open market or private sale
|
Direct |
1,498
-1.5%
|
$31,458
$21.18 P/Share
|
|
Apr 05
2023
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
569
-0.56%
|
$11,380
$20.82 P/Share
|